US2022162251A1PendingUtilityA1
Nucleotide analogues
Est. expiryNov 6, 2035(~9.3 yrs left)· nominal 20-yr term from priority
C07C 323/60C07D 207/46C07C 2603/18C12Q 1/6869C07C 323/12C12Q 1/6876C07D 207/40Y02P20/55C09B 1/00C07H 19/14C07H 19/10C09B 11/24C07F 7/1804C09B 5/2436C09B 23/16C09B 23/166C12P 19/34C09B 23/083C12Q 1/6811
78
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides methods, compositions, mixtures and kits utilizing deoxynucleoside triphosphates comprising a 3′-O position capped by a group comprising methylenedisulfide as a cleavable protecting group and a detectable label reversibly connected to the nucleobase of said deoxynucleoside. Such compounds provide new possibilities for future sequencing technologies, including but not limited to Sequencing by Synthesis.
Claims
exact text as granted — not AI-modified1 .- 47 . (canceled)
48 . A composition comprising:
i) at least one deoxynucleoside triphosphate according to the following structure:
wherein B is a nucleobase; and
ii) at least one labeled deoxynucleoside triphosphate according to the following structure:
wherein D is selected from the group consisting of an azide, disulfide alkyl, disulfide substituted alkyl groups, disulfide allyl, and disulfide substituted allyl groups; B is a nucleobase; Linker comprises a cleavable oxymethylenedisulfide-containing site core, wherein said cleavable site core is selected from the group consisting of:
wherein R 1 and R 2 are independently selected alkyl groups; and Label is a label.
49 . The composition according to claim 48 , wherein the nucleobase of i) or ii) is a non-natural nucleobase analog selected from the group consisting of 7-deaza guanine, 7-deaza adenine, 2-amino, 7-deaza adenine, and 2-amino adenine.
50 . The composition according to claim 49 , wherein the nucleobase of i) and ii) is identical.
51 . The composition according to claim 49 , wherein the nucleobase of i) and ii) is not identical.
52 . The composition according to claim 48 , wherein said label is selected from the group consisting of fluorophore dyes, energy transfer dyes, mass-tags, biotin, and haptenes.
53 . The composition according to claim 48 , wherein the composition further comprises a polymerase.
54 . The composition according to claim 53 , wherein the composition further comprises a primer.
55 . The composition according to claim 54 , wherein the primer is hybridized to a nucleic acid template.
56 . The composition according to claim 55 , wherein said nucleic acid template is immobilized.Join the waitlist — get patent alerts
Track US2022162251A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.